タイトル | Effects of HLA single chain trimer design on peptide presentation and stability. |
---|
ジャーナル・号・ページ | Front Immunol, Vol. 14, Page 1170462-1170462, Year 2023 |
---|
掲載日 | 2021年11月5日 (構造データの登録日) |
---|
著者 | Finton, K.A.K. / Rupert, P.B. / Friend, D.J. / Dinca, A. / Lovelace, E.S. / Buerger, M. / Rusnac, D.V. / Foote-McNabb, U. / Chour, W. / Heath, J.R. ...Finton, K.A.K. / Rupert, P.B. / Friend, D.J. / Dinca, A. / Lovelace, E.S. / Buerger, M. / Rusnac, D.V. / Foote-McNabb, U. / Chour, W. / Heath, J.R. / Campbell, J.S. / Pierce, R.H. / Strong, R.K. |
---|
リンク | Front Immunol / PubMed:37207206 |
---|
手法 | X線回折 |
---|
解像度 | 2.35 - 2.78 Å |
---|
構造データ | PDB-7sqp: Single chain trimer HLA-A*02:01 (Y108C) with HPV.16 E7 peptide YMLDLQPETTDL 手法: X-RAY DIFFRACTION / 解像度: 2.53 Å PDB-7sr0: Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPET 手法: X-RAY DIFFRACTION / 解像度: 2.54 Å PDB-7sr3: Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPETTDL 手法: X-RAY DIFFRACTION / 解像度: 2.49 Å PDB-7sr4: Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPETTDLYC 手法: X-RAY DIFFRACTION / 解像度: 2.59 Å PDB-7sr5: Single chain trimer HLA-A*02:01 (Y108C, A163C) with Wilms tumor protein peptide RMFPNAPYL 手法: X-RAY DIFFRACTION / 解像度: 2.35 Å PDB-7srk: Single chain trimer HLA-A*24:02 (Y108C, A163C) with 8mer peptide YPPVPETF 手法: X-RAY DIFFRACTION / 解像度: 2.5 Å PDB-7ssh: Single chain trimer HLA-A*02:01 (Y108A) with HPV.16 E7 peptide YMLDLQPETTDLYC 手法: X-RAY DIFFRACTION / 解像度: 2.73 Å PDB-7st3: Consequences of HLA single chain trimer mutations on peptide presentation and binding affinity 手法: X-RAY DIFFRACTION / 解像度: 2.78 Å PDB-7stg: Consequences of HLA single chain trimer mutations on peptide presentation and binding affinity 手法: X-RAY DIFFRACTION / 解像度: 2.7 Å |
---|
化合物 | |
---|
由来 | - human papillomavirus type 16 (パピローマウイルス)
- pongo pygmaeus (オランウータン)
- homo sapiens (ヒト)
- lama glama (ラマ)
|
---|
キーワード | IMMUNE SYSTEM / HLA / VHH / HPV / SCT / IMMUNE SYSTEM/VIRAL PROTEIN / IMMUNE SYSTEM-VIRAL PROTEIN complex |
---|